Perioperative Camrelizumab Plus Rivoceranib vs Surgery Alone in Hepatocellular Carcinoma

Written by

admin

in

By Matthew Stenger
Posted: 10/31/2025 9:00:00 AM

Last Updated: 10/31/2025 8:25:06 AM

In a Chinese phase II/III trial (CARES-009) reported in The Lancet, Wang et al found that the addition of perioperative camrelizumab…

Continue Reading

More posts